argenx SE reported $4.25B of revenue over the trailing twelve months, +89% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $4.25B (to FY2025). Net income: $1.29B, trailing twelve months to FY2025. Free cash flow: $679M, trailing twelve months to FY2025. Operating margin: 25%, trailing twelve months to FY2025.

ARGXargenx SE

Healthcare

$824.98+12% 1Y

$824.98

$663.9352 weeks$1.1K

ARGX as reported

argenx SE reported $4.25B of revenue over the trailing twelve months, +89% on the year before. 10 reported series are charted on this page, each one as filed.

$4.25B

Revenue, trailing twelve months · to FY2025 · +89% against the twelve months before

Net income: $1.29B
Net income · +55% year on year · trailing twelve months to FY2025
Free cash flow: $679M
Free cash flow · −903% year on year · trailing twelve months to FY2025
Operating margin: 25%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for ARGX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$4.25B	+89%	FY2025
Net income	$1.29B	+55%	FY2025
EPS	$19.57	+53%	FY2025
Gross margin	89%	n/a	FY2025
Operating margin	25%	n/a	FY2025
Net margin	30%	n/a	FY2025
ROE	18%	n/a	FY2025
ROA	15%	n/a	FY2025
Free cash flow	$679M	−903%	FY2025
P/E	42.2	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.